Industry Research Reports

Home > Reports > Chemical & Material > Global Indapamide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Indapamide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Chemical & Material

Published Date: 2025-11-09

Pages: 104 Pages

Report ld: 5404004

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Indapamide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Indapamide API market competitiveness, regional economic performance, and supply chain configurations.

Indapamide(CAS： 26807-65-8) is a sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine. It has a role as an antihypertensive agent and a diuretic.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Indapamide API market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

Otto Brandes
Biotechnica Pharma Global
CHEMO
Hepartex
Octavius Pharma Pvt. Ltd
Torrent Pharmaceuticals Limited
PharmaZell
Recipharm AB
Bioindustria L.I.M. Spa
Ipca Laboratories
Laboratori Alchemia Srl
Supra Chemicals
Suzhou Lixin Pharmaceutical
Refarmed Chemicals
Osmopharm
Tianjin Pacific Chemical & Pharma
Guangzhou Tosun Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Above 98 %
Above 99 %

Segment by Application

Tablets
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Indapamide API market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Above 99 % in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Others in India).

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Indapamide API value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Indapamide API Product Scope

1.2 Indapamide API by Type

1.2.1 Global Indapamide API Sales by Type (2020 & 2024 & 2031)

1.2.2 Above 98 %

1.2.3 Above 99 %

1.3 Indapamide API by Application

1.3.1 Global Indapamide API Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Tablets

1.3.3 Others

1.4 Global Indapamide API Market Estimates and Forecasts (2020-2031)

1.4.1 Global Indapamide API Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Indapamide API Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Indapamide API Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Indapamide API Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Indapamide API Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Indapamide API Sales Market Share by Region (2020-2025)

2.2.2 Global Indapamide API Revenue Market Share by Region (2020-2025)

2.3 Global Indapamide API Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Indapamide API Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Indapamide API Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 Europe Indapamide API Market Size and Prospective (2020-2031)

2.4.2 China Indapamide API Market Size and Prospective (2020-2031)

2.4.3 India Indapamide API Market Size and Prospective (2020-2031)

2.4.4 Mid East & Africa Indapamide API Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Indapamide API Historic Market Review by Type (2020-2025)

3.1.1 Global Indapamide API Sales by Type (2020-2025)

3.1.2 Global Indapamide API Revenue by Type (2020-2025)

3.1.3 Global Indapamide API Price by Type (2020-2025)

3.2 Global Indapamide API Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Indapamide API Sales Forecast by Type (2026-2031)

3.2.2 Global Indapamide API Revenue Forecast by Type (2026-2031)

3.2.3 Global Indapamide API Price Forecast by Type (2026-2031)

3.3 Different Types Indapamide API Representative Players

4 Global Market Size by Application

4.1 Global Indapamide API Historic Market Review by Application (2020-2025)

4.1.1 Global Indapamide API Sales by Application (2020-2025)

4.1.2 Global Indapamide API Revenue by Application (2020-2025)

4.1.3 Global Indapamide API Price by Application (2020-2025)

4.2 Global Indapamide API Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Indapamide API Sales Forecast by Application (2026-2031)

4.2.2 Global Indapamide API Revenue Forecast by Application (2026-2031)

4.2.3 Global Indapamide API Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Indapamide API Application

5 Competition Landscape by Players

5.1 Global Indapamide API Sales by Players (2020-2025)

5.2 Global Top Indapamide API Players by Revenue (2020-2025)

5.3 Global Indapamide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Indapamide API as of 2024)

5.4 Global Indapamide API Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Indapamide API, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Indapamide API, Product Type & Application

5.7 Global Key Manufacturers of Indapamide API, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 Europe Market: Players, Segments, Downstream and Major Customers

6.1.1 Europe Indapamide API Sales by Company

6.1.1.1 Europe Indapamide API Sales by Company (2020-2025)

6.1.1.2 Europe Indapamide API Revenue by Company (2020-2025)

6.1.2 Europe Indapamide API Sales Breakdown by Type (2020-2025)

6.1.3 Europe Indapamide API Sales Breakdown by Application (2020-2025)

6.1.4 Europe Indapamide API Major Customer

6.1.5 Europe Market Trend and Opportunities

6.2 China Market: Players, Segments, Downstream and Major Customers

6.2.1 China Indapamide API Sales by Company

6.2.1.1 China Indapamide API Sales by Company (2020-2025)

6.2.1.2 China Indapamide API Revenue by Company (2020-2025)

6.2.2 China Indapamide API Sales Breakdown by Type (2020-2025)

6.2.3 China Indapamide API Sales Breakdown by Application (2020-2025)

6.2.4 China Indapamide API Major Customer

6.2.5 China Market Trend and Opportunities

6.3 India Market: Players, Segments, Downstream and Major Customers

6.3.1 India Indapamide API Sales by Company

6.3.1.1 India Indapamide API Sales by Company (2020-2025)

6.3.1.2 India Indapamide API Revenue by Company (2020-2025)

6.3.2 India Indapamide API Sales Breakdown by Type (2020-2025)

6.3.3 India Indapamide API Sales Breakdown by Application (2020-2025)

6.3.4 India Indapamide API Major Customer

6.3.5 India Market Trend and Opportunities

6.4 Mid East & Africa Market: Players, Segments, Downstream and Major Customers

6.4.1 Mid East & Africa Indapamide API Sales by Company

6.4.1.1 Mid East & Africa Indapamide API Sales by Company (2020-2025)

6.4.1.2 Mid East & Africa Indapamide API Revenue by Company (2020-2025)

6.4.2 Mid East & Africa Indapamide API Sales Breakdown by Type (2020-2025)

6.4.3 Mid East & Africa Indapamide API Sales Breakdown by Application (2020-2025)

6.4.4 Mid East & Africa Indapamide API Major Customer

6.4.5 Mid East & Africa Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Otto Brandes

7.1.1 Otto Brandes Company Information

7.1.2 Otto Brandes Business Overview

7.1.3 Otto Brandes Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Otto Brandes Indapamide API Products Offered

7.1.5 Otto Brandes Recent Development

7.2 Biotechnica Pharma Global

7.2.1 Biotechnica Pharma Global Company Information

7.2.2 Biotechnica Pharma Global Business Overview

7.2.3 Biotechnica Pharma Global Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Biotechnica Pharma Global Indapamide API Products Offered

7.2.5 Biotechnica Pharma Global Recent Development

7.3 CHEMO

7.3.1 CHEMO Company Information

7.3.2 CHEMO Business Overview

7.3.3 CHEMO Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.3.4 CHEMO Indapamide API Products Offered

7.3.5 CHEMO Recent Development

7.4 Hepartex

7.4.1 Hepartex Company Information

7.4.2 Hepartex Business Overview

7.4.3 Hepartex Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Hepartex Indapamide API Products Offered

7.4.5 Hepartex Recent Development

7.5 Octavius Pharma Pvt. Ltd

7.5.1 Octavius Pharma Pvt. Ltd Company Information

7.5.2 Octavius Pharma Pvt. Ltd Business Overview

7.5.3 Octavius Pharma Pvt. Ltd Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Octavius Pharma Pvt. Ltd Indapamide API Products Offered

7.5.5 Octavius Pharma Pvt. Ltd Recent Development

7.6 Torrent Pharmaceuticals Limited

7.6.1 Torrent Pharmaceuticals Limited Company Information

7.6.2 Torrent Pharmaceuticals Limited Business Overview

7.6.3 Torrent Pharmaceuticals Limited Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Torrent Pharmaceuticals Limited Indapamide API Products Offered

7.6.5 Torrent Pharmaceuticals Limited Recent Development

7.7 PharmaZell

7.7.1 PharmaZell Company Information

7.7.2 PharmaZell Business Overview

7.7.3 PharmaZell Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.7.4 PharmaZell Indapamide API Products Offered

7.7.5 PharmaZell Recent Development

7.8 Recipharm AB

7.8.1 Recipharm AB Company Information

7.8.2 Recipharm AB Business Overview

7.8.3 Recipharm AB Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Recipharm AB Indapamide API Products Offered

7.8.5 Recipharm AB Recent Development

7.9 Bioindustria L.I.M. Spa

7.9.1 Bioindustria L.I.M. Spa Company Information

7.9.2 Bioindustria L.I.M. Spa Business Overview

7.9.3 Bioindustria L.I.M. Spa Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Bioindustria L.I.M. Spa Indapamide API Products Offered

7.9.5 Bioindustria L.I.M. Spa Recent Development

7.10 Ipca Laboratories

7.10.1 Ipca Laboratories Company Information

7.10.2 Ipca Laboratories Business Overview

7.10.3 Ipca Laboratories Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Ipca Laboratories Indapamide API Products Offered

7.10.5 Ipca Laboratories Recent Development

7.11 Laboratori Alchemia Srl

7.11.1 Laboratori Alchemia Srl Company Information

7.11.2 Laboratori Alchemia Srl Business Overview

7.11.3 Laboratori Alchemia Srl Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Laboratori Alchemia Srl Indapamide API Products Offered

7.11.5 Laboratori Alchemia Srl Recent Development

7.12 Supra Chemicals

7.12.1 Supra Chemicals Company Information

7.12.2 Supra Chemicals Business Overview

7.12.3 Supra Chemicals Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.12.4 Supra Chemicals Indapamide API Products Offered

7.12.5 Supra Chemicals Recent Development

7.13 Suzhou Lixin Pharmaceutical

7.13.1 Suzhou Lixin Pharmaceutical Company Information

7.13.2 Suzhou Lixin Pharmaceutical Business Overview

7.13.3 Suzhou Lixin Pharmaceutical Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.13.4 Suzhou Lixin Pharmaceutical Indapamide API Products Offered

7.13.5 Suzhou Lixin Pharmaceutical Recent Development

7.14 Refarmed Chemicals

7.14.1 Refarmed Chemicals Company Information

7.14.2 Refarmed Chemicals Business Overview

7.14.3 Refarmed Chemicals Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.14.4 Refarmed Chemicals Indapamide API Products Offered

7.14.5 Refarmed Chemicals Recent Development

7.15 Osmopharm

7.15.1 Osmopharm Company Information

7.15.2 Osmopharm Business Overview

7.15.3 Osmopharm Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.15.4 Osmopharm Indapamide API Products Offered

7.15.5 Osmopharm Recent Development

7.16 Tianjin Pacific Chemical & Pharma

7.16.1 Tianjin Pacific Chemical & Pharma Company Information

7.16.2 Tianjin Pacific Chemical & Pharma Business Overview

7.16.3 Tianjin Pacific Chemical & Pharma Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.16.4 Tianjin Pacific Chemical & Pharma Indapamide API Products Offered

7.16.5 Tianjin Pacific Chemical & Pharma Recent Development

7.17 Guangzhou Tosun Pharmaceutical

7.17.1 Guangzhou Tosun Pharmaceutical Company Information

7.17.2 Guangzhou Tosun Pharmaceutical Business Overview

7.17.3 Guangzhou Tosun Pharmaceutical Indapamide API Sales, Revenue and Gross Margin (2020-2025)

7.17.4 Guangzhou Tosun Pharmaceutical Indapamide API Products Offered

7.17.5 Guangzhou Tosun Pharmaceutical Recent Development

8 Indapamide API Manufacturing Cost Analysis

8.1 Indapamide API Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Indapamide API

8.4 Indapamide API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Indapamide API Distributors List

9.3 Indapamide API Customers

10 Indapamide API Market Dynamics

10.1 Indapamide API Industry Trends

10.2 Indapamide API Market Drivers

10.3 Indapamide API Market Challenges

10.4 Indapamide API Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Indapamide API Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Indapamide API Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Indapamide API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Indapamide API Sales (Kg) by Region (2020-2025)

Table 5. Global Indapamide API Sales Market Share by Region (2020-2025)

Table 6. Global Indapamide API Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Indapamide API Revenue Share by Region (2020-2025)

Table 8. Global Indapamide API Sales (Kg) Forecast by Region (2026-2031)

Table 9. Global Indapamide API Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Indapamide API Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Indapamide API Revenue Share Forecast by Region (2026-2031)

Table 12. Global Indapamide API Sales by Type (Kg) & (2020-2025)

Table 13. Global Indapamide API Sales Share by Type (2020-2025)

Table 14. Global Indapamide API Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Indapamide API Price by Type (US$/Kg) & (2020-2025)

Table 16. Global Indapamide API Sales by Type (Kg) & (2026-2031)

Table 17. Global Indapamide API Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Indapamide API Price by Type (US$/Kg) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Indapamide API Sales by Application (Kg) & (2020-2025)

Table 21. Global Indapamide API Sales Share by Application (2020-2025)

Table 22. Global Indapamide API Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Indapamide API Price by Application (US$/Kg) & (2020-2025)

Table 24. Global Indapamide API Sales by Application (Kg) & (2026-2031)

Table 25. Global Indapamide API Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Indapamide API Price by Application (US$/Kg) & (2026-2031)

Table 27. New Sources of Growth in Indapamide API Application

Table 28. Global Indapamide API Sales by Company (Kg) & (2020-2025)

Table 29. Global Indapamide API Sales Share by Company (2020-2025)

Table 30. Global Indapamide API Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Indapamide API Revenue Share by Company (2020-2025)

Table 32. Global Indapamide API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Indapamide API as of 2024)

Table 33. Global Market Indapamide API Average Price by Company (US$/Kg) & (2020-2025)

Table 34. Global Key Manufacturers of Indapamide API, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Indapamide API, Product Type & Application

Table 36. Global Key Manufacturers of Indapamide API, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. Europe Indapamide API Sales by Company (2020-2025) & (Kg)

Table 39. Europe Indapamide API Sales Market Share by Company (2020-2025)

Table 40. Europe Indapamide API Revenue by Company (2020-2025) & (US$ Million)

Table 41. Europe Indapamide API Revenue Market Share by Company (2020-2025)

Table 42. Europe Indapamide API Sales by Type (2020-2025) & (Kg)

Table 43. Europe Indapamide API Sales Market Share by Type (2020-2025)

Table 44. Europe Indapamide API Sales by Application (2020-2025) & (Kg)

Table 45. Europe Indapamide API Sales Market Share by Application (2020-2025)

Table 46. China Indapamide API Sales by Company (2020-2025) & (Kg)

Table 47. China Indapamide API Sales Market Share by Company (2020-2025)

Table 48. China Indapamide API Revenue by Company (2020-2025) & (US$ Million)

Table 49. China Indapamide API Revenue Market Share by Company (2020-2025)

Table 50. China Indapamide API Sales by Type (2020-2025) & (Kg)

Table 51. China Indapamide API Sales Market Share by Type (2020-2025)

Table 52. China Indapamide API Sales by Application (2020-2025) & (Kg)

Table 53. China Indapamide API Sales Market Share by Application (2020-2025)

Table 54. India Indapamide API Sales by Company (2020-2025) & (Kg)

Table 55. India Indapamide API Sales Market Share by Company (2020-2025)

Table 56. India Indapamide API Revenue by Company (2020-2025) & (US$ Million)

Table 57. India Indapamide API Revenue Market Share by Company (2020-2025)

Table 58. India Indapamide API Sales by Type (2020-2025) & (Kg)

Table 59. India Indapamide API Sales Market Share by Type (2020-2025)

Table 60. India Indapamide API Sales by Application (2020-2025) & (Kg)

Table 61. India Indapamide API Sales Market Share by Application (2020-2025)

Table 62. Mid East & Africa Indapamide API Sales by Company (2020-2025) & (Kg)

Table 63. Mid East & Africa Indapamide API Sales Market Share by Company (2020-2025)

Table 64. Mid East & Africa Indapamide API Revenue by Company (2020-2025) & (US$ Million)

Table 65. Mid East & Africa Indapamide API Revenue Market Share by Company (2020-2025)

Table 66. Mid East & Africa Indapamide API Sales by Type (2020-2025) & (Kg)

Table 67. Mid East & Africa Indapamide API Sales Market Share by Type (2020-2025)

Table 68. Mid East & Africa Indapamide API Sales by Application (2020-2025) & (Kg)

Table 69. Mid East & Africa Indapamide API Sales Market Share by Application (2020-2025)

Table 70. Otto Brandes Company Information

Table 71. Otto Brandes Description and Business Overview

Table 72. Otto Brandes Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 73. Otto Brandes Indapamide API Product

Table 74. Otto Brandes Recent Development

Table 75. Biotechnica Pharma Global Company Information

Table 76. Biotechnica Pharma Global Description and Business Overview

Table 77. Biotechnica Pharma Global Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 78. Biotechnica Pharma Global Indapamide API Product

Table 79. Biotechnica Pharma Global Recent Development

Table 80. CHEMO Company Information

Table 81. CHEMO Description and Business Overview

Table 82. CHEMO Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 83. CHEMO Indapamide API Product

Table 84. CHEMO Recent Development

Table 85. Hepartex Company Information

Table 86. Hepartex Description and Business Overview

Table 87. Hepartex Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 88. Hepartex Indapamide API Product

Table 89. Hepartex Recent Development

Table 90. Octavius Pharma Pvt. Ltd Company Information

Table 91. Octavius Pharma Pvt. Ltd Description and Business Overview

Table 92. Octavius Pharma Pvt. Ltd Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 93. Octavius Pharma Pvt. Ltd Indapamide API Product

Table 94. Octavius Pharma Pvt. Ltd Recent Development

Table 95. Torrent Pharmaceuticals Limited Company Information

Table 96. Torrent Pharmaceuticals Limited Description and Business Overview

Table 97. Torrent Pharmaceuticals Limited Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 98. Torrent Pharmaceuticals Limited Indapamide API Product

Table 99. Torrent Pharmaceuticals Limited Recent Development

Table 100. PharmaZell Company Information

Table 101. PharmaZell Description and Business Overview

Table 102. PharmaZell Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 103. PharmaZell Indapamide API Product

Table 104. PharmaZell Recent Development

Table 105. Recipharm AB Company Information

Table 106. Recipharm AB Description and Business Overview

Table 107. Recipharm AB Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 108. Recipharm AB Indapamide API Product

Table 109. Recipharm AB Recent Development

Table 110. Bioindustria L.I.M. Spa Company Information

Table 111. Bioindustria L.I.M. Spa Description and Business Overview

Table 112. Bioindustria L.I.M. Spa Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 113. Bioindustria L.I.M. Spa Indapamide API Product

Table 114. Bioindustria L.I.M. Spa Recent Development

Table 115. Ipca Laboratories Company Information

Table 116. Ipca Laboratories Description and Business Overview

Table 117. Ipca Laboratories Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 118. Ipca Laboratories Indapamide API Product

Table 119. Ipca Laboratories Recent Development

Table 120. Laboratori Alchemia Srl Company Information

Table 121. Laboratori Alchemia Srl Description and Business Overview

Table 122. Laboratori Alchemia Srl Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 123. Laboratori Alchemia Srl Indapamide API Product

Table 124. Laboratori Alchemia Srl Recent Development

Table 125. Supra Chemicals Company Information

Table 126. Supra Chemicals Description and Business Overview

Table 127. Supra Chemicals Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 128. Supra Chemicals Indapamide API Product

Table 129. Supra Chemicals Recent Development

Table 130. Suzhou Lixin Pharmaceutical Company Information

Table 131. Suzhou Lixin Pharmaceutical Description and Business Overview

Table 132. Suzhou Lixin Pharmaceutical Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 133. Suzhou Lixin Pharmaceutical Indapamide API Product

Table 134. Suzhou Lixin Pharmaceutical Recent Development

Table 135. Refarmed Chemicals Company Information

Table 136. Refarmed Chemicals Description and Business Overview

Table 137. Refarmed Chemicals Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 138. Refarmed Chemicals Indapamide API Product

Table 139. Refarmed Chemicals Recent Development

Table 140. Osmopharm Company Information

Table 141. Osmopharm Description and Business Overview

Table 142. Osmopharm Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 143. Osmopharm Indapamide API Product

Table 144. Osmopharm Recent Development

Table 145. Tianjin Pacific Chemical & Pharma Company Information

Table 146. Tianjin Pacific Chemical & Pharma Description and Business Overview

Table 147. Tianjin Pacific Chemical & Pharma Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 148. Tianjin Pacific Chemical & Pharma Indapamide API Product

Table 149. Tianjin Pacific Chemical & Pharma Recent Development

Table 150. Guangzhou Tosun Pharmaceutical Company Information

Table 151. Guangzhou Tosun Pharmaceutical Description and Business Overview

Table 152. Guangzhou Tosun Pharmaceutical Indapamide API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 153. Guangzhou Tosun Pharmaceutical Indapamide API Product

Table 154. Guangzhou Tosun Pharmaceutical Recent Development

Table 155. Production Base and Market Concentration Rate of Raw Material

Table 156. Key Suppliers of Raw Materials

Table 157. Indapamide API Distributors List

Table 158. Indapamide API Customers List

Table 159. Indapamide API Market Trends

Table 160. Indapamide API Market Drivers

Table 161. Indapamide API Market Challenges

Table 162. Indapamide API Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Indapamide API Product Picture

Figure 2. Global Indapamide API Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Indapamide API Sales Market Share by Type in 2024 & 2031

Figure 4. Above 98 % Product Picture

Figure 5. Above 99 % Product Picture

Figure 6. Global Indapamide API Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Indapamide API Sales Market Share by Application in 2024 & 2031

Figure 8. Tablets Examples

Figure 9. Others Examples

Figure 10. Global Indapamide API Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Indapamide API Sales Growth Rate (2020-2031) & (US$ Million)

Figure 12. Global Indapamide API Sales (Kg) Growth Rate (2020-2031)

Figure 13. Global Indapamide API Price Trends Growth Rate (2020-2031) & (US$/Kg)

Figure 14. Indapamide API Report Years Considered

Figure 15. Global Market Indapamide API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 16. Global Indapamide API Revenue Market Share by Region: 2020 VS 2024

Figure 17. Europe Indapamide API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. Europe Indapamide API Sales (Kg) Growth Rate (2020-2031)

Figure 19. China Indapamide API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. China Indapamide API Sales (Kg) Growth Rate (2020-2031)

Figure 21. India Indapamide API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. India Indapamide API Sales (Kg) Growth Rate (2020-2031)

Figure 23. Mid East & Africa Indapamide API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. Mid East & Africa Indapamide API Sales (Kg) Growth Rate (2020-2031)

Figure 25. Global Indapamide API Revenue Share by Type (2020-2025)

Figure 26. Global Indapamide API Sales Share by Type (2026-2031)

Figure 27. Global Indapamide API Revenue Share by Type (2026-2031)

Figure 28. Global Indapamide API Revenue Share by Application (2020-2025)

Figure 29. Global Indapamide API Revenue Growth Rate by Application in 2020 & 2024

Figure 30. Global Indapamide API Sales Share by Application (2026-2031)

Figure 31. Global Indapamide API Revenue Share by Application (2026-2031)

Figure 32. Global Indapamide API Sales Share by Company (2024)

Figure 33. Global Indapamide API Revenue Share by Company (2024)

Figure 34. Global 5 Largest Indapamide API Players Market Share by Revenue in Indapamide API: 2020 & 2024

Figure 35. Indapamide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 36. Manufacturing Cost Structure of Indapamide API

Figure 37. Manufacturing Process Analysis of Indapamide API

Figure 38. Indapamide API Industrial Chain

Figure 39. Channels of Distribution (Direct Vs Distribution)

Figure 40. Distributors Profiles

Figure 41. Bottom-up and Top-down Approaches for This Report

Figure 42. Data Triangulation

Figure 43. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Indapamide API market? zhanKai

The top companies in the global Indapamide API market are Otto Brandes、Biotechnica Pharma Global、CHEMO.

Related Reports

Indapamide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Indapamide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 153
USD 3950.00
(Single User License)
Global Indapamide API Market Research Report 2026
The global Indapamide API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 150
USD 2900.00
(Single User License)
Global Indapamide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Indapamide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 174
USD 4900.00
(Single User License)
Indapamide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Indapamide API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 145
USD 3950.00
(Single User License)
Global Indapamide API Market Research Report 2025
The global market for Indapamide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 110
USD 2900.00
(Single User License)
Global Indapamide API Market Research Report 2024
Indapamide(CAS： 26807-65-8) is a sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine. It has a role as an antihypertensive agent and a diuretic.
Published Date: 2024-02-07
Pages: 113
USD 2900.00
(Single User License)

Indapamide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Indapamide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 153
USD 3950.00 (Single User License)
Global Indapamide API Market Research Report 2026
The global Indapamide API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 150
USD 2900.00 (Single User License)
Global Indapamide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Indapamide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 174
USD 4900.00 (Single User License)
Indapamide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Indapamide API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 145
USD 3950.00 (Single User License)
Global Indapamide API Market Research Report 2025
The global market for Indapamide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 110
USD 2900.00 (Single User License)
Global Indapamide API Market Research Report 2024
Indapamide(CAS： 26807-65-8) is a sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine. It has a role as an antihypertensive agent and a diuretic.
Published: 2024-02-07
Pages: 113
USD 2900.00 (Single User License)